Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Telik (TELK) gained $0.48 (14%) to $3.94 on Monday after announcing that
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury